Wojciech Michno

Wojciech Michno

Auto-generated profile, based on publicly available information

Wojciech Michno

Uppsala University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2017 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
IKIbrahim Kaya
Ibrahim Kaya
DBDimitri Brinet
Dimitri Brinet
WMWojciech Michno
Wojciech Michno
MBMehmet Başkurt
Mehmet Başkurt
HZHenrik Zetterberg
Henrik Zetterberg
JHJörg Hanrieder
Jörg Hanrieder

2 October 2023 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
FQFangfei Qu
Fangfei Qu
SBSiqi C. Brough
Siqi C. Brough
WMWojciech Michno
Wojciech Michno
CMChioma J. Madubata
Chioma J. Madubata
GHGriffin G. Hartmann
Griffin G. Hartmann
JSJulien Sage
Julien Sage

10 January 2017 in ACS Chemical Neuroscience
Verified
Journal Article
Open access
IKIbrahim Kaya
Ibrahim Kaya
DBDimitri Brinet
Dimitri Brinet
WMWojciech Michno
Wojciech Michno
SSStina Syvanen
Stina Syvanen
DSDag Sehlin
Dag Sehlin
JHJörg Hanrieder
Jörg Hanrieder
The major pathological hallmarks of Alzheimer’s disease (AD) are the progressive aggregation and accumulation of beta-amyloid (Aβ) and hyperphosphorylated tau protein into neurotoxic deposits. Aβ aggregation has been suggested as the critical early inducer, driving the disease progression. However, the factors that promote neurotoxic Aβ aggregation remain elusive. Imaging mass spectrometry (IMS) is a powerful technique to comprehensively elucidate the spatial distribution patterns of lipids, peptides, and proteins in biological tissue sections. In the present study, matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS)-based imaging was used on transgenic Alzheimer’s disease mouse (tgArcSwe) brain tissue to investigate the sphingolipid microenvironment of individual Aβ plaques and elucidate plaque-associated sphingolipid alterations. Multivariate data analysis was used to interrogate the IMS data for identifying pathologically relevant, anatomical features based on their lipid chemical profile. This approach revealed sphingolipid species that distinctly located to cortical and hippocampal deposits, whose Aβ identity was further verified using fluorescent amyloid staining and immunohistochemistry. Subsequent multivariate statistical analysis of the spectral data revealed significant localization of gangliosides and ceramides species to Aβ positive plaques, which was accompanied by distinct local reduction of sulfatides. These plaque-associated changes in sphingolipid levels implicate a functional role of sphingolipid metabolism in Aβ plaque pathology and AD pathogenesis. Taken together, the presented data highlight the potential of imaging mass spectrometry as a powerful approach for probing Aβ plaque-associated lipid changes underlying AD pathology.

6 April 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
IKIbrahim Kaya
Ibrahim Kaya
WMWojciech Michno
Wojciech Michno
DBDimitri Brinet
Dimitri Brinet
YIYasmine Iacone
Yasmine Iacone
GZGiulia Zanni
Giulia Zanni
JHJörg Hanrieder
Jörg Hanrieder

1 June 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
WMWojciech Michno
Wojciech Michno
IKIbrahim Kaya
Ibrahim Kaya
SNSofie Nyström
Sofie Nyström
LGLaurent Guerard
Laurent Guerard
KNK. Peter R. Nilsson
K. Peter R. Nilsson
JHJörg Hanrieder
Jörg Hanrieder

1 May 2019 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
WMWojciech Michno
Wojciech Michno
PWPatrick M. Wehrli
Patrick M. Wehrli
HZHenrik Zetterberg
Henrik Zetterberg
KBKaj Blennow
Kaj Blennow
JHJörg Hanrieder
Jörg Hanrieder